Julius Asubonteng, PhD

Director
Regeneron
Tarrytown, United States

Disclosure information not submitted.

Presentation(s):

• Immune-Related Adverse Events of Anti-PD-(L)1 Immunotherapy With and Without Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Evidence Study

  Tuesday, August 27, 2024
  1:00 PM – 1:15 PM CEST